Anesthesia 1

  1. Physical status, category I
    • an animal with no organic disease, or for which the disease is localized and not causing any systemic disturbance.  
    • ie, healthy animal undergoing elective castration surgery, etc.
  2. Physical status, category II
    • Animal with mild systemic disturbance, may or may not be associated with surgical complaint.  Able to compensate, no clinical signs.  
    • Mild anemia, neonate/geriatric, obese, simple fracture without shock, controlled diabetic.
  3. Physical status, category III
    • Animal with moderate systemic disturbance which may or may not be associated with the surgical procedure
    • ie. Moderate anemia, mitral valve insufficiency, respiratory insufficiency, dehydration, fever, cachexia
  4. Physical status, category IV
    • animal with extreme systemic disturbance that interferes with the animal's normal activities; the condition is a constant threat to the animal's life.  
    • ie. uncompensated mitral valve insufficiency, respiratory insufficiency, uremia, toxemia, strangulated hernia, hemorrhage, high fever, emaciation
  5. Physical status, category V
    • moribund (medical treatment cannot improve animal's condition, sx required immediately, not expected to live more than 24h with or without sx).  Disease condition advanced.  
    • ie extreme shock and dehydration, severe trauma, terminal malignancy or infection
  6. Physical status, category E
    Emergency operation, any physical status may be operated on as necessary.  Greater risk than non-emergency status due to lack of time for full work-up.
  7. Why use anticholinergics/parasympathetics as premedicants
    • reduce secretions
    • prevent bradycardia
    • reduce gastrointestinal motility
  8. Why NOT use anticholinergics/parasympathetics as premedicants
    • decrease GI motility
    • slight increase in myocardial work load and cardiac dysrrhythmias
  9. Tranquilizer/ataractic/neuroleptic
    "a state of stoical indifference".  Best in quiet environment, can be roused. Increased dose = NO increase in calming, just side effects.
  10. neurolepanalgesic
    tranquilizer plus opioid analgesic (acepromazine plus opioid)
  11. Acepromazine
    • tranquilizer
    • slow onset, long duration. 
    • Antiemetic, antihistaminic
    • decreases circulating catecholamines
    • may induce seizures?
    • Causes hypotension (alpha1 blocker, vasodilation in splanchnic bed and skin), hypothermia, decreased PCV, decreased ventilation, penile prolapse in horses
  12. Droperidol - InnovarVet
    • Butyrophenone (tranquilizer), anti-emetic in InnovarVet
    • made dogs and cats bite owners 24h later.  Not available in US.
  13. Azaperone - Stresnil, Sui-calm
    • butyrophenone (major tranquilizer)
    • used in wildlife capture and to decrease stress in feeder pig introduction
  14. sedative
    • increase dose, increase effect (unlike tranquilizers)
    • Alpha-2
    • Benzodiazepines
    • Chloral hydrate (oral for ketone-induced seizures in cattle, hepatotoxic)
    • ? Barbituates
    • Avertin (2,2,2-Tribromoethanol plus amylene hydrate - IP in mice, no analgesia
  15. Benzodiazepines
    • Sedative, non-specific muscle relaxation (often used with ketamine or opioids)
    • reverse with flumazenil
    • may cause paradoxical excitement (lose learned inhibition)
    • decrease need for other drugs for anesthesia
    • reliable sedation for young, old or sick
  16. diazepam
    • benzodiazepine sedative
    • not water soluble, so no IM or SQ
    • ONLY with propylene glycol (no CRI, not too fast IV or hemolysis, pain, thrombosis)
    • minimal cardiopulmonary (doesn't really cross bbb)
  17. Midazolam, Versed
    • sedative benzodiazepine
    • 3.5 pH to make it water-soluble (absorbed), increases in blood to become lipid soluble (cross bbb)
    • no propylene glycol, so CRI okay
    • produces amnesia (retrograde)
  18. zolazepam
    • benzodiazepine sedative
    • combined with tiletamine in Telazol
    • (cats - zolazepam longer so LONG recovery, dogs tiletamine longer so dissociative recovery)
    • used for fractious - can give low volume in any route to get an animal down.
  19. Alpha-2 agonists
    • reliable dose-dependent sedation in horses (tractable but don't go down, watch for kick)
    • analgesia
    • Vasoconstriction increases resistance, BP increases, bradycardia (persistent), then decrease CO, decrease BP, HR stays the same.
    • Lose thermoregulation
    • inital emesis then decreased GI motility
    • hyperglycemia (beta cells)
    • increase urine production (inhibit ADH)
    • xylazine, detomidine, medetomidine, dexmedetomidine, romifidine
    • REVERSAL: atipamazole, yohimbine
  20. xylazine
    • alpha-2 agonist sedative
    • susceptibility differs between species.  Sheep get interstitial pulmonary edema, hypoxia.
    • normal family of side effects
    • shorter-lasting than detomidine  (20-30 mins)
  21. detomidine
    • alpha-2 agonist sedative
    • used in horses, cheap
    • more potent than xylazine
    • longer-lasting than xylazine (60+ minutes)
    • same family of side effects
  22. medetomidine
    • alpha-2 agonist sedative, no longer available for domestic species, racemic mixure of isomers (only one works).  
    • dogs and cats
    • lasts a LONG time
    • usu needs to be reversed with atipamazole
    • used for capture still
  23. dexmedetomidine
    • alpha-2 agonist sedative, dextro-rotatory isomer (so twice as potent as medetomidine, except not)
    • used in CRI to supplement anesthesia, sedation in ICU, analgesia post-op.  Clinically similar to medetomidine
  24. Romifidine
    • alpha-2 agonist sedative
    • licensed for horses
    • good sedative and analagesia
    • intermediate duration of action (~45m?)
    • more specific at alpha-2 receptors than xylazine.
  25. ANS and energy
    • sympathetic NS expends energy
    • parasympathetic accumulates energy
  26. Principle site of ANS organization is the
    hypothalamus
  27. tonicity
    holds organs in a state of intermediate activation, which can be increased or decreased
  28. SNS preganglionic originate from the
    thoracolumbar region, synapse at sympathetic trunk/ganglia (first is short, second is long).  Preganglionic can also synapse directly on adrenal medulla to produce epi
  29. Sympathetic response extent
    • DIFFUSE response because postganglionic outnumber preganglionic
    • augmented by release of EPI from adrenal glands.
  30. adrenal gland acts as the
    post-synaptic neuron.  Pre-gang neurons contact the gland directly.  Cells of adrenal come from neural cells.
  31. preganglionic fibers (both divisions) are
    Myelinated (faster)
  32. Postganglionic fibers (both divisions) are
    not myelinated (slower)
  33. PNS preganglionic originate from
    • craniosacral - from brainstem and sacral spinal cord.  
    • Vagus is ~75%, innervates heart, lungs, esophagus, stomach, SI, colon, liver, gallbladder, pancreas, ureters.  Sacral is the rest.
    • Long preganglionic, short postganglionic
  34. PNS postganglionic fibers
    short, near or within viscera.
  35. parasympathetic response extent
    • 1:1 or 3:1, so focused, localized, discrete and limited response, not like mass effect SNS.  
    • Vagal bradycardia occurs without changes in GI motility or salivation
  36. Neurotransmitters
    • preganglionic of both release ACh
    • postganglionic of PNS release ACh
    • postganglionic of SNS release norepinephrine
    • Synthesized in neurons.  Rate depends on ANS ACTIVITY
  37. Cholinergic receptors
    • at effector organ in PNS, at ganglia of all ANS (presynaptic), at neuromuscular junction.  
    • Muscarinic (ANS) and nicotinic (muscle), both respond to ANS
  38. effects of muscarinic receptors (postganglionic PNS)
    • bradycardia, decreased inotropism (SA and AV nodes), bronchoconstriction, salivation, GI hypermotility, increased gastric secretion.  
    • Blocked by antimuscarinic/anticholinergic (atropine)
  39. adrenergic receptor drug sensitivity
    • alpha sensitive to NE and Epi
    • beta sensitive to isoproterenol and epi
    • dopamine works with different receptor
  40. alpha adrenergic receptors
    • alpha 1: found in vascular muscle, NE and Epi, activation = vasoconstriction, blockade = dilation (acepromazine is alpha blocker)
    • alpha 2: pre- and post-synaptic.  Post = vasoconstriction, pre = blocks negative feedback for NE release, sedation
  41. Beta adrenergic receptors
    • beta 1: myocardium, SA, ventricular conduction, + inotrope and + chronotrope
    • beta 2: smooth muscle of vessels and bronchi.  stim  =  relaxation
  42. dopaminergic receptors
    • CNS, blood vessels, possibly dilates renal vasculature.  
    • dopamine is a precursor for epi and NE, activates alpha and beta as well as DA1.
  43. adrenergic receptors
    • alpha1, alpha2, beta1, beta2, DA1
    • dynamic: synthesized or removed, internalized or externalized; inversely proportional to amt of catecholamines in plasma. More causes downregulation, chronic antagonist use causes upregulation (withdrawal)
  44. baroreceptor reflex
    baroreceptors in carotid bodies and aortic arch (stretch receptors) stim vagus and glossopharyngeal nerves to inhibit or increase SNS tone, change HR and BP.
  45. sympathomimetic vs sympatholytic (and para)
    mimetic mimics the SNS, lytic opposes, looks like PNS (but isn't).  describes mechanism of action, not result (so sympathomimetic does not = parasympatholytic, dobutamine does not = atropine, but effects are similar)
  46. ways autonomic drugs can work (modes of action)
    • Prejunction membrane: interfere with neurotransmitter release (alpha2 agonists), stimulate transmitter release (ephedrine), interfere with reuptake
    • Postjunction membrane: directly stimulate receptor or interfere with natural agonist of transmitter
  47. antimuscarinic/anticholinergic drugs and MOA
    • block postjunctional receptors, prevent action of ACh on heart and vessels/bronchioles.  Reverse or prevent vagally mediated bradycardia (increase HR, which increases ABP and CO)
    • reduced secretions, bronchodilation, slow GI motility, important in horses (and rabbits)
    • atropine and glycopyrrolate (antimuscarinic, no effect on nicotinic)
  48. paradoxical bradycardia of atropine/glycopyrrolate
    blocks negative feedback loop on presynaptic first, increases ACh so causes bradycardia (negative chronotrope and dromotrope) for a while before post-synaptic overwhelmed.  Dose-dependent
  49. sympathomimetic drugs and MOA
    • catecholamines (endogenous and synthetic, direct and indirect).  Act on alpha and/or beta receptors
    • direct: activate receptors directly, work by themselves and don't depend on endogenous catecholamines
    • indirect (synthetic non-catecholamines): stimulate release of endogenous NE (CAN BE DEPLETED).  Could also have direct effects.  EPHEDRINE
  50. clearance of catecholamines
    • rapid inactivation by MAO and COMT
    • fast uptake into prejunctional
    • cleared by lungs
    • SHORT duration (~5min)
    • not liposoluble so limited central effects, PERIPHERAL (airways, vessels)
  51. clearance of synthetic non-catecholamines
    • Phenylephrine
    • only cleared by MAO (not COMT)
    • duration can be longer (but not all)
  52. Ephinephrine (adrenaline)
    • catecholamine (endogenous)
    • non-selective, alpha 1 and 2, beta 1 and 2. 
    • Increases contractility, HR, vasoconstriction AND vasoconstriction (at dif capillary beds), bronchodilation
    • uses: anaphylactic shock, asystole/CPR, CV support
    • "reverse effect": if alpha blocker given (acepromazine), high dose epi can't vasoconstrict so lots of vasodilation, makes things worse
    • short duration (~5 mins) (all symp)
  53. norepinephrine (noradrenaline)
    • catecholamine
    • like epi without (WEAK) beta2.  No vaso- or bronchodilation. 
    • vasoconstrictor and positive inotrope (BP support)
    • short duration (~5 mins) (all symp)
  54. dopamine
    • catecholamine (endogenous)
    • immediate precursor of NE
    • nonspecific agonist of D, alpha and beta.  
    • low dose: renal vasodilation (increase afferent)
    • medium dose: B1 + inotrope
    • high dose: alpha1 vasoconstriction
    • short duration (~5 mins) (all symp)
  55. isoproterenol
    • synthetic catecholamine
    • most potent beta agonist (non-selective) = + chronotrope, inotrope, bronchodilation, vasodilation
    • used to increase HR in heart block, pacemaker implantation.  
    • severe vasodilation (hypotension) and arrhythmias limit use
    • short duration (~5 mins) (all symp)
  56. dobutamine
    • synthetic catecholamine
    • selective B1 agonist, weak B2 agonist
    • + inotrope, modest vasodilation to increase CO and muscular perfusion
    • often used in horses to decrease postanesthetic myopathy
    • short duration (~5 mins) (all symp)
  57. phenylephrine
    • direct agonist of alpha1 receptors
    • vasoconstriction causes increase in arterial BP
    • reflex bradycardia (baroreceptor reflex)
    • short duration (~5 mins) (all symp)
  58. ephedrine
    • synthetic non-catecholamine
    • INDIRECT AND DIRECT alpha and beta agonist
    • activates receptors and releases NE (mostly this) (also releases epi since see B2?)
    • lasts longer than most catecholamines
    • increase HR, contractility, APT and CO
    • can deplete NE with repeated doses
  59. beta adrenergic antagonists (beta blockers)
    • esmolol
    • suppress or reduce sympathetic tone, treat dysrrhythmias, antihypertensive, tx of pheochromocytoma
  60. beta adrenergic agonists
    • albuterol (beta2 agonist)
    • mainly bronchodilators
  61. vasopressin
    not a catecholamine, but used for vasoconstriction
  62. anticholinergics as premedication
    • PRO: reduce secretions, prevent bradycardia, reduce GI motility
    • CON: reduce GI motility, increase myocardial work and cardiac dysrrhythmias.  
    • good for ophthalmic surgery, cervical spinal cord decompression, endoscopy, with large dose mu opioids and cholinesterase inhibitors
    • don't use with preexisting tachyarrhythmias, maybe alpha2 due to vasoconstriction, bradycardia, low CO
  63. atropine
    • anticholinergic.  Broken down (atropinase) slowest in dogs, fastest in rabbits.  
    • pupil dilation (not in birds), reduced lacrimation, crosses BBB, transient bradycardia after IV (presynaptic ACh inhibits ACh release), crosses placenta.
    • reduced lacrimation, transient bradycardia after IV (presynaptic ACh inhibits ACh release), crosses bbb and placenta.
  64. glycopyrrolate
    • anticholinergic
    • longer lasting than atropine, pupil dilation
    • DOES NOT cross BBB or placenta.  
    • increases gastric pH, so aspiration causes less damage
    • expensive
  65. tranquilizers = ataractic = neuroleptic
    quiet environment needed, increased dose doesn't increase calm, just adverse effects.
  66. neuroleptanalgesic
    • tranquilizer plus opioid
    • ace + opioid
  67. acepromazine
    • phenothiazine tranquilizer
    • slow onset, long duration
    • antiemetic
    • decreases circulating catecholamines
    • antihistamine
    • may induce seizures (increase in EEG activity)
    • Adverse: hypotension (alpha1 adrenergic = vasodilation in splanchnic and skin), hypothermia (central depression plus hypotension), decreased PV (spleen relaxes with apha1 block), decreased ventilation (minor), penile prolapse in horses
    • contraindication: hypovolemia, hepatic disease, coagulopathy, pediatric, old, breeding stallions
  68. drug that decreases gastric volume or pH
    metoclopramide (prokinetic)
  69. drug that neutralizes stomach contents with non-particulate agent
    sodium citrate
  70. drugs that decrease gastric acid production
    famotidine
  71. patients at risk for gastric reflux include
    • emergency sx
    • pregnancy
    • morbid obesity
    • diabetic gastroparesis/full stomach
    • post-sx
    • pre-op fasting >24h (+ lower pH)
    • increased age (+ lower pH)
    • intra-abdominal surgery
  72. esophageal strictures
    post-surgical complication!
  73. metoclopramide
    • pro-kinetic, decreases gastric volume or pH
    • antagonizes inhibitory neurotransmitter (dopamine), augments ACh release and sensitizes muscarinic of GI smooth muscle
    • crosses BBB, could cause acute dystonic rxns and extrapyramidal
  74. famotidine/ranitidine
    • specific and competitive histamine H2-receptor antagonist at parietal cells
    • gastric pH raised, volume of secretions reduced
    • 45-60mins pre-anesthesia
    • rapid IV = cardiac arrhythmias
  75. sodium citrate
    non-particulate (clear) antacid used as prophylaxis against aspiration pneumonitis
  76. Ondansetron
    antagonizes 5-HT3 receptors both centrally and peripherally to control nausea and/or vomiting
  77. cerenia (maropitant)
    neurokinin (NK1) receptor antagonist to block pharmacological action of substance P in CNS to control nausea and vomiting
  78. noxious stimulus
    • one that is actually or potentially damaging to tissue.  
    • one of intensity and quality adequate to stimulate nocioceptors.
  79. pain
    • defined by IASP in 1979
    • An unpleasant sensory and EMOTIONAL experience associated with actual or potential tissue damage, or described in terms of such damage
  80. neuropathic pain
    • pain due to damage to nervous system
    • less responsive to traditional analgesics
    • characterized by spontaneous paresthesia and paroxysms of pain, pain caused by normal movement, hyperalgesia and allodynia
  81. nocioceptors
    • nonencapsulated receptor organs responding preferentially to noxious stimuli.  
    • Attached to nocioceptive neurons/fibers (pseudounipolar)
    • widely distributed, high stimulus threshold (just noxious)
    • Includes A-delta vs C fibers
  82. Nocioceptorsclassified by diameter, myelination, and conduction velocity of parent fibers.  What are the two fiber types?  Compare pain they cause, degree of myelination, thickness and conduction velocity (just who is faster)
    • A-delta: fast/first pain, sharp pricking, light myelination, thicker.  Variable conduction. 
    • C: slow pain, burning, smaller, non-myelinated so usu slower.
  83. A-delta fibers
    • pricking, sharp, aching pain
    • lightly myelinated
    • 2-5 microns
    • conduction velocity = highly variable
    • first pain
  84. C fibers
    • burning pain
    • unmyelinated
    • <2 microns
    • conduction velocity of 0.5-2.0m/sec
    • most polymodal (heat, pressure, vibration, too)
    • more numerous in visceral tissues
  85. four physiological processes involved in nocioception
    • transduction
    • transmission
    • modulation
    • perception
  86. transduction and transducers
    • first physiological process of nocioception
    • translation of physical energy into electrical activity by nocioceptors via transducers (mechano-, chemo-, thermo-).  Most are polymodal.  Ionotropic (faster) or metabotropic (slower)
  87. algogenic chemicals
    inflammatory soup that is released from neurons (and non-neurons) upon tissue injury.  Includes inflammatory mediators, cytokines and neurotrophins.  Things like bacteria are also algogenic, so infection can cause pain.
  88. Inflammatorymediatorscauseperipheralsensitizationofneuronsby binding to _______ receptors and activating intracellular signaling cascades
    Metabotropic
  89. neurve transection leads to formation of a
    Neuroma
  90. hyperalgesia (3 characteristics)
    sensitization of nocioceptors (decreased threshold, increased response, spontaneous activation) causes left shift on stimulus-response graph, so lower magnitude is painful
  91. peripheral sensitization
    inflammatory mediators bind to metabotropic receptors to increase probability that future stimulus will activate receptor.  Preventing generation of inflammatory mediators helps prevent peripheral sensitization (PREEMPTIVE ANALGESIA)
  92. transmission
    • 2nd physiologic process in nocioception
    • propagation of an action potential along peripheral nocioceptive neurons and into/throughout CNS
  93. The _______ appears to be the major nocioceptivepathway (except for the head) in carnivores
    spinocervicothalamic
  94. The ________ is the major nocioceptivepathway in the head
    trigeminothalamic
  95. T/F: pain in viscera is usually worse as a result of stimuli like ischemia or dissensionofa hollow viscous than as a result of surgical incision
    True
  96. T/F: nocioceptive neurons traveling from viscera to CNS travel to the CNS in EITHER the glossopharyngeal/vagus nerve and a pair of spinal nerves OR two pairs of spinal nerves
    True
  97. T/F: the RAS is responsible for making sure an organism pays attention to a noxious stimulus
    True
  98. Stimulation of hypothalamus by nocioceptive pathways causes release of catecholaminea and pituitary hormones
    True
  99. T/F: the Limbic System ensures an organism will link noxious stimuli with negative emotion
    True
  100. primary neurotransmitter released by first-order nocio neurons in spinal cord dorsal horn?  Name two receptors to which it binds on post-synaptic membrane
    GLutamate (excitatory), binds to AMPA, NMDA, G-protein coupled receptors
  101. Spinal cord Dorsal horn is divided into how many laminae of Reed?  Which are main sites of terminati of first-order A-delta and C nocio neruons?
    A Is I and IV-V, C is I and II.
  102. Spinal cord plasticity/ synaptic long-term potentiation (“central sensitization” or “wind-up”) is induced by an increase in intracellular _____ ions in the second-order neuron in the dorsal horn due to opening of the ion channel of the _____ receptor. Two things must happen for this ion channel to become permeable to these ions; name these two things.
    Calcium due to NMDA receptors. Requires glutamate/glycinebindingand removal of Mg++ plug
  103. Interneurons (2)
    • inhibitory: Gaba and/or glycine, endogenous opioid agonists (endorphins)
    • excitatory: glutamate, involved in reflex arcs (withdrawal)
  104. T/F: Synaptic long-term potentiation can be avoided by preventing noxious input into the spinal cord before it starts (with analgesic drugs), but NOT by general anesthesia alone (inhalant anesthesia).
    True
  105. With regard to interneurons and the Gate Theory:   Stimulation of A-beta (innocuous touch) fibers can stimulate _____, which then inhibit second-order (projection) neurons. This is why transcutaneous electrical nerve stimulation (TENS), massage, and other therapies that stimulate A-beta fibers can decrease pain.
    Inhibitory interneurons, serotonin and norepinephrine
  106. T/F: Pain induces protein catabolism, which can interfere with healing of wounds or surgical incisions.
    True
  107. Gate theory:  The ___ and the ___ (two areas in the brainstem) project to the dorsal horn of the spinal cord, where they inhibit first-order neurons, second-order neurons, and excitatory interneurons. They also release the neurotransmitters ___ and ___, which stimulate inhibitory interneurons; these inhibitory interneurons then inhibit first- and second-order nociceptive neurons.
    PeriaqueductalGrey Matter and Rostral Ventromedial Medulla System, _______ and _______
  108. Modulation
    • third physiological process in nocioception
    • modification of nocioception in the dorsal horn (protective).  Interneurons (excitatory vs inhibitory)
  109. Gate theory
    • inhibitory interneurons are "gate cells", a "closed gate" (stimulated) stops noxious signals from ascending to brain
    • massage relieves pain!
  110. cognitive and emotional factors can control pain processing
    periqueductal grey matter (PAG) gets input from higher structures to control pain processing - disinhibits nucleus raphe magnus of rostral ventromedial medulla
  111. ways to stop nocioception
    • direct postsynaptic inhibition of second order (projection neurons)
    • inhibition of neurotransmitter release from first-order neurons
    • excitation of inhibitory interneurons (release endogenous opioids)
    • inhibition of excitatory interneurons
  112. Perception
    • fourth physiological process of nocioception
    • nocio neurons project from thalamus to somatosensory cortex
    • changes in somatosensory and motor cortices due to unchecked pain (phantom limb pain)
    • destruction of cortex does not eliminate pain perception
  113. Physiologic effects of pain (9)
    • stim hypothalamus (increase CRH, ACTH, cortisol), decrease protein synthesis, increase catabolism, decrease healing
    • increase glucagon and decrease insulin (hyperglycemia, glycogenolysis, gluconeogenesis)
    • immune system suppression (infection)
    • increase GHRH and GH
    • Catecholamine release (increased preload, contractility, stroke volume, heart rate, cardiac output, arterial blood pressure, increased oxygen consumption)
    • retention of water and Na, excretion of K (RAAS activation, ADH release triggered by angiotensin II, stimulation of thirst center in hypothalamus)
    • respiratory effects (central hyperventilation and respiratory alkalosis, hypoventilation and respiratory acidosis if ventilation painful)
    • decreased GI motility
    • Urine retention
  114. General anesthesia
    drug-induced reversible condition including unconsciousness (hypnosis), amnesia, analgesia and immobility with simultaneous stability of the autonomic, CV, respiratory, and thermoregulatory systems.
  115. Types of general anesthetics
    • vapors: isofluorane, sevofluorane, desfluorane
    • gases: N2O, Xenon
    • Injectables: barbituate hypnotics, non-barbituate hypnotics (propofol), dissociative (ketamine), steroids (alfaxalone)
  116. Where does amnesia occur?
    hippocampus, amygdala, and cortex (learning and memory).  GABA involved
  117. Where does hypnosis work?
    • thalamus, hypothalamus, cortex and brainstem.  
    • Conscious involves arousal (RAS, reticular formation and locus coerulus) and awareness (cortex).
  118. Where does immobility come from
    inhibition of spinal reflex pathways - SPINAL CORD
  119. what does brainstem control
    ventilation and cardiac function (Isofluorane and propofol augment inhibition of GABA)
  120. Anatomical location of anesthesia
    • SC and brainstem: immobility and autonomic homeostasis
    • hippocampus: amnesia
    • hypnosis: cortical and subcortical structures and brianstem
  121. Meyer-Overton Rule
    • all anesthetics act at same molecular site -- the lipid bilayer.  MORE LIPID SOLUBLE IS MORE POTENT!!!
    • 3 exceptions: many lipid-soluble don't cause anesthesia, cutoff phenomenon (most lipid soluble stop working all together), isomers/enantiomers are not equally potent, but are equally soluble.
    • So not a great rule
  122. Protein theories of general anesthesia
    meyer-overton rule exceptions explained by lipid pockets in proteins.  How much light it produces = potency.  Too large or isomer, won't fit in pocket of protein, so better theory.
  123. Ways general anesthesia affects CNS function (2)
    neuronal excitability, communication between neurons (synapsis)
  124. excitability
    • the propensity of a neuron to generate and propagate an action potential.  
    • Determined by resting membrane potential, threshold potential, size/propagation of action potential
    • anesthetics hyperpolarize cortical and motor spinal neurons
    • hyperpolarization correlates with anesthetic potency
    • inhibits initiation of action potential, but too small to stop propagation
  125. major excitatory neurotransmitter in CNS
    • glutamate
    • release decreased by general anesthesia (inhibition of RELEASE), maybe mediated by Na, K channels
    • N2)O and Xenon and Ketamine inhibit POSTSYNAPTIC response to glutamate on NMDA receptors
  126. major inhibitory neurotransmitter in CNS
    • GABA
    • increase Cl- conductance, hyperpolarizes cell
  127. 2 effects of general anesthesia on GABA-A receptors
    • potentiation: increases current elicited by low concentrations of GABA
    • direct action: ability to activate GABA-A in the absence of GABA
    • general anesthesia increase affinity of GABA to GABA-A.  Do not affect conductance, just increase frequency of opening or time to open
  128. Leak channels
    • background K+ channels (voltage independant).  
    • General anesthetics activate these channels.  Silences spontaneous firing of some neurons.
  129. Na channels
    • ion channels that change based on membrane potential
    • we used to think they were insensitive to general anesthetics but now it looks like isofluorane and halothane decrease some subtypes.  Small inhibition of channels causes large inhibition of synaptic function
  130. hyperpolarization-activated cyclic nucleotide-gated channel
    • activated by voltage and cAMP
    • "pacemaker channels" in brain and heart
    • anesthetics inhibit these channels and reduce amplitude
    • more resistant to propofol and ketamine
  131. laryngeal mask
    ET tube with little cup on end that sits over larynx, not inserted into trachea.  Can't protect from aspiration, can't suction deeply.
  132. murphy eye
    hole in the end of ET tube
  133. pre-oxygenation
    increases time to desaturation if something goes wrong.
  134. T/F: opioids can cause hyperthermia in some species, such as cats, due to increased locomotion and/or central hypothalamic mechanism
    True
  135. name the three endogenous opioid peptides
    Enkephalins, dynorphins, beta-endorphins
  136. narcotic
    Potent morphine-like analgesic drug
  137. opioid
    All exogenous substances that bind to opioid receptors and produce some agonist activity
  138. Opioid MOA
    • CNS Presynaptic (main): increased K+ efflux and Ca++ channel inactivation = inhibition of neurotransmitter release, inhibition of adenylyl cyclase = decrease in neurotransmitter production
    • CNS Postsynaptic: increased K+ efflux = hyperpolarization
    • CNS: upregulates antinocioceptive neurons (PAG and raphe nucleus)
    • Peripheral: inhibits neurotransmitter release (joints, etc)
  139. Opioid receptors
    • Mu: analgesia, side effects
    • Delta: 
    • Kappa:
  140. Opioids cause nausea and vomiting by _________ in dogs and cats
    stimulating the chemoreceptor trigger zone
  141. T/F: opioid-induced hypoventilation is dose-dependent
    True
  142. T/F: CV depression is significant with opioids
    False
  143. morphine releases the inflammatory mediator _______
    Histamine
  144. T/F: there is strong evidence that opioid-induced ileum leads to colic in horses
    false
  145. Which urinary system complication is common when opioids, especially morphine, are administered into the epidural or subarachnoid spaces
    Urinary retention -- suppression of detrusor and sensation of urge
  146. T/F: morphine can be injected intraarticularly or applied topically to corneas to provide analgesia
    True
  147. T/F: morphine injected epidural can provide analgesia for as long as 24h
    True
  148. which opioid that also inhibits serotonin and norepinephrine reuptake is commonly given orally to dogs at home?
    Tramadol
  149. T/F: the COX selectivity of a given NSAID is related to adverse effects in healthy GI tissues
    True
  150. T/F: the COX selectivity of a given NSAID is unrelated to efficacy in given patient
    True
  151. Name the major side effects of NSAID administration
    GI (gastritis/enteritis/ulceration/perforation),acuterenal failure, hepatic damage
  152. When is renal failure most commonly seen as a side effect of NSAID administration
    High doses, concurrent corticosteroids,dehydration/hypovolemia,poorly managed anesthesia, cardiac failure, preexisting renal disease
  153. Name the contraindications for NSAID administration
    concurrent NSAID or corticosteroid administration, coagulopathy, renal disease, hepatic disease, GI disease, hypovolemia, mast cell tumors
  154. Which NSAID has a warning against multiple dosing in cats
    Meloxicam
  155. newly licensed oral NSAID for dogs and cats
    rofenacoxib/onsior
  156. Most common NSAID given to horses for orthopedic pain and the one for horses with colic
    • Ortho: phenylbutazone
    • colic: flunixin/banamine
  157. Name the only NSAID that is FDA-approved for use in cattle
    Flunixin
  158. Morphine
    • Full Mu agonist opioid analgesic
    • 24+ hours epidural (more hydrophilic than others), topical to corneas, intra-articular
    • releases histamine
    • nauseating and emetic
  159. Hydromorphone and oxymorphone
    • synthetic full mu agonist opioids
    • dogs and cats
    • nauseating and emetic
  160. methadone
    • Synthetic full mu agonist and NMDA antagonist, alpha-2 agonist.  
    • Prolonged duration (12h) after SQ, trans-mucosal in cats
    • less emetic (but still nausea)
  161. fentanyl
    • Synthetic opioid full mu agonist in dogs and cats, small rumenants and camelids
    • patches and long-acting transdermal also available
  162. tramadol
    • Weak mu agonist and serotonin/norepinephrine reuptake inhibitor, may cause serotonin release in CNS
    • ORAL, but dogs produce little of active metabolite.
    • NOT WITH MAO INHIBITORS OR SEROTONERGIC DRUGS or will get serotonin syndrome
  163. butorphanol
    • Mu antagonist (competitive), kappa agonist
    • little analgesia
    • ceiling effect on side effects
    • Best opioid sedative.  
    • Also mild pain, CRI for colic in horses, antitussive
  164. buprenorphine
    • Semisynthetic Mu partial agonist, binds TIGHTLY and dissociates slowly.  HARD TO ANTAGONIZE
    • 6-8h
    • oral-transmucosal in cats
    • Simbadol is extended-release for cats, 24h
  165. opioid receptor antagonists
    • Naloxone, naltrexone
    • displace mu and kappa agonists but don't activate receptors
    • reverse side effects as well as analgesia
  166. NSAID MOA
    inhibit eicosanoid production by inhibiting COX (3 isoforms)
  167. COX1
    Produces PGE2 (vasodilation, nocioceptor sensitization, beneficial GI effects) and TXA2 (vasoconstriction, platelet aggregation)
  168. COX2
    • Produces PGE2 (vasodilation, nocioceptor sensitization, beneficial GI effects) and PGI2 (vasodilation, inhibition of platelet aggregation, only in inflamed tissues, expressed in GI tract). 
    • Stimulates renin release and alters renal blood flow
    • ONLY "SAFER" DUE TO DECREASED GI EFFECTS IN HEALTHY GI TISSUES
  169. Carprofen
    • COX2 preferential NSAID
    • approved for dogs (also in cats, horses, cattle in Europe)
  170. Meloxicam
    • COX2 preferential NSAID
    • cats (only one), dogs, LA, birds, pocket pets, zoo/wildlife
  171. Robenacoxib
    • Onsior
    • great for kidneys in cats
    • new
  172. phenylbutazone
    • Non-specific COX inhibitor
    • orthopedic pain in horses
    • ILLEGAL in dairy cattle over 20 months
  173. Flunixin meglumine
    • non-specific COX inhibitor
    • horses and farm animals
    • ONLY NSAID approved by FDA for cattle
  174. nerve order in brachial plexus
    Suprascapular (rotation, too superficial), musculocutaneous (AIM HERE, flexion, biceps), radial (extension, triceps), median/ulnar (rotation)
  175. femoral block
    • Limb stretched causally, feel for pectineus (HARD) and femoral artery, femoral nerve is just cranial.  There will be a POP when you go through fascia, otherwise you'll get electrical stimulation but NO BLOCK
    • under vastus medialis, between rectus femoris and pectineus
  176. Sciatic block
    Nerve between greater trochanter and ischiatic tuberosity, under biceps femoris and cranial to semiten, semimem.  There are perineal/fibular and tibial branches
  177. Layers to go through for an epidural
    Skin, fat, muscle, ligamentum flavum/arcuate ligament
  178. epidural contraindications
    • Bleeding disorders (could hit the internal vertebral venus plexus)
    • uncorrected hypovolemia (vasodilation)
    • infection at injection site, sepsis or bacteremia (venous plexus puncture, seeding infection into epidural space, abscess)
  179. most common drugs for local anesthetic
    Local like lidocaine, bupivicaine, opioids and alpha-2 agonists, or combinations
  180. equipment for epidural injection
    • Tuohy needle is dull and bent, lets you feel the pop and hanging drop
    • DON'T USE A SPINAL NEEDLE
  181. placement for epidural
    • lumbosacral space: between spinous process of L7 and median sacral crest, big dip you fall into
    • Coxococcigeal space: between Cd1 and Cd2
    • You know you're right because of "pop" from ligamentum flavum or hanging drop
  182. Types of dead space
    • Alveolar
    • anatomical
    • machine
  183. functional residual capacity
    volume of gas left in the lungs at the end of a passive expiration
  184. closing volume
    Volume of gas left in the lungs when the airways start to close
  185. minimum alveolar concentration
    concentration of anesthetic vapor in the alveoli at 1 atm that produces immobility in 50% of patients exposed to a painful stimulus
  186. ventilatoryvariable guidelines for domestic
    • Tidal volume: 10 mls/kg
    • minute volume: 150 mls/kg-min
    • metabolic oxygen: mls/kg-min
  187. ways to increase CO2 in a P
    • Wrong gas in (don't change soda lime)
    • decreased alveolar ventilation(decreased central drive (drugs), increased resistance (ET tube), decreased compliance (obesity, pregnant))
    • diffusion limitation
    • increased venous admixture (PDA, heart defect)
    • mixed venous oxygen (less O2 coming back than should be, like anemia, Pyrexia)
  188. V/Q values
    • Ventilationwithout perfusion = infinity
    • 1 = perfect
    • 0 = perfusion without ventilation
  189. Gas vs vapor and significance
    • N2O is a gas, rest are vapors
    • vapors are liquid at room temp, must be mixed with gas, need vaporizer.  Agent and temp dependent.  Saturated vapor pressure is the MAX pressure you can get.  
    • Gas can be 0-100% , we can give a max of ~70% to avoid hypoxia.  Gas at room temp.
  190. MAC
    Minimum alveolar concentration at which 50% don't respond to surgical incisions.  50% don't move in response to noxious stimuli.
  191. Pros and Cons of MAC
    • Pros: reproducible throughout species; End-tidal levels of anesthetic are in equilibrium with pressure in brain and plasma
    • cons: quantal (yes or no, anesthesia is not), only counts 50%(populations), depends on choice of end-point, represents no MOVEMENT, not no pain or hypnosis.
  192. Things that affect MAC
    • other drugs: additive or synergistic (pre-anesthetics like opioids, sedative, N2O)
    • temperature: hyperthermia increases mac
    • Age: decreases with age
    • thyroid: Increase equals increase?
    • pregnancy: decreases MAC
  193. Effects of inhalational aesthetics on the CNS (5), CV (5), resp (4)
    • CNS: Dose-dependent depression of CNS.  Increase cranial blood flow and intracranial pressure, blunts autoregulation.  Decrease brain's requirement for oxygen (CMRO2)
    • CV: dose- and agent-dependent depression.  Halothane depresses myocardial contractility (reduces CO and ABP, blunts baroreceptor, sensitizes heart to catecholamines).  Rest are minimal, better for baro, cause vasodilation (hypotension, not contractility), don't sensitize to catecholamines
    • resp: reduction of tidal volume, normal response to CO2 depressed, blunt response to hypoxia, bronchodilators
  194. dif between halothane and other vapors
    • More prominent increase of cerebral blood flow and intracranial pressure
    • depresses myocardial contractility (rather than vasodilation like the others)
    • blunts baroreceptor function
    • sensitizes heart to catecholamines
  195. N2O
    • Need 200% to anesthetize, we can't give more than 70%.  But causes NMDA block so we give for analgesia. Multi-modal, decreases need for ISO to decrease vasodilation. 
    • Increases cerebral blood flow and intracranial pressure and CMRO2, cerebral metabolic requirement for oxygen
    • minimal change in minute ventilation but depresses response to hypoxia
    • CV: DIRECT is myocardial depression, INDIRECT is catecholamine stim like ketamine.  Net is SNS but can run out of catecholmamines and see depression
    • MOVES INTO HOLLOW CAVITIES, avoid in pneumothorax, GDV etc. 
    • Diffusion hypoxia: displaces O2, so after discontinuation will move back into alveoli from blood and cause hypoxia, give O2 for 10 mins after.
  196. Diffusion hypoxia
    N2O discontinued, diffuses quickly into alveoli to equilibrate and can cause massive hypoxia, keep giving O2 for 10 minutes after discontinuing
  197. T/F: Propofol (unless it’s Propoflo 28TM) must be discarded six hours after the bottle is opened because it supports bacterial growth.
    True
  198. What is propofol’s mechanism of action?
    Decreases rate of dissociation of GABA from GABA-A receptors
  199. Name two reasons why propofol has a short duration of action
    Rapid redistribution to other tissues like fat and rapid metabolism (liver, lungs)
  200. What are the CNS effects of propofol
    Decreases cerebral metabolic rate for O2, cerebral blood flow and intracranial pressure
  201. What are the CV effects of propofol
    Decreased myocardial contractility and vasodilation = hypotension, blunts baroreceptor reflex
  202. T/F: Propofol stimulates ventilation
    True
  203. what effect does propofol have on intraocular pressure
    Decrease
  204. Propofol can cause which hematological condition if given repeatedly over days?
    Oxidative injury to RBC = Heinz body anemia
  205. The dissociative anesthetics are antagonists at the _________ receptor but appear to have other effects too
    NMDA
  206. T/F: The dissociative anesthetics produce intense analgesia, and ketamine is used as a CRI for pain
    True - ketamine
  207. What is special about ketamine in the cat
    Excreted unchanged by kidneys mostly
  208. What are the CNS effects of the dissociative anesthetics
    Seizures, increased cerebral blood flow and intracranial pressure, emergence delirium/hallucinations
  209. What are the CV effects of dissociative anesthetics
    Indirect CV stimulation, direct myocardial depression
  210. What are the respiratory effects of the dissociative anesthetics
    Don't depress ventilation as much as protocol, bronchodilator, pharyngeal/laryngeal reflexes maintained
  211. what is the MOA of etomidate
    Enhances affinity of GABA for GABA-A (no analgesic)
  212. Name the two ways etomidate is metabolized
    Hydrolysis by hepatic microsomes like enzymes and plasma set erases, excreted in urine and bile
  213. Main clinical use of etomidate
    • IV induction of general anesthesia
    • especially good for CV patients (also renal, hepatic, hypovolemic)
  214. T/F: Etomidate can cause hemolysis because it is dissolved in propylene glycol
    True
  215. What is the major endocrine side effect of etomidate
    Adrenocortical suppression
  216. Which induction agent is classified as a neurosteroid?
    Alfaxalone
  217. What is the MOA of alfaxalone?
    Enhances GABA-mediated neurodepression (like propofol, etomidate, etc)
  218. How is alfaxalone metabolized and excreted?
    Hepatic glucuronidation, then kidney
  219. T/F: Cats metabolize alfaxalone faster than dogs
    False, slower
  220. T/F: alfaxalone causes dose-dependent cardiorespiratory depression
    true
  221. What is the MOA of barbiturates
    Decrease dissociation of GABA and open Cl- channel.  No analgesic
  222. T/F: barbiturates increase intracranial pressure
    False, decrease
  223. Name the CV and resp effects of barbiturates
    • CV: vasodilation, myocardial depression, arrhythmias
    • Resp: dose-dependent depression
  224. What happens if a barbiturate is accidentally administered outside the vein
    Tissue sloughing
  225. Advantages and disadvantages of inhalant inductions
    • Minimally metabolized so decrease liver burden, don't have to inject
    • no rapid control of airway, stressful, excitement phase if not premed, can vomit/regurgitate and we don't have airway control
  226. in which patients are opioid inductions most commonly performed
    Moribund (extreme CV stability)
Author
XQWCat
ID
330017
Card Set
Anesthesia 1
Description
Va Anesthesia 1
Updated